Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,272 | -114,151 | -59,681 | -204,703 | -145,893 |
| Depreciation Amortization | 485 | 996 | 485 | 640 | 222 |
| Other Working Capital | -1,646 | 7,039 | 5,401 | 3,266 | -956 |
| Other Operating Activity | 614 | 8,528 | 2,769 | 115,328 | 107,501 |
| Operating Cash Flow | $-29,819 | $-97,588 | $-51,026 | $-85,469 | $-39,126 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -274 | -4,210 | -1,681 | -3,912 | -3,634 |
| Other Investing Activity | 33,127 | -77,821 | -71,527 | -1,426 | -1,405 |
| Investing Cash Flow | $32,853 | $-82,031 | $-73,208 | $-5,338 | $-5,039 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -125 | -90 | 34 | 206,424 | 203,920 |
| Financing Cash Flow | $-125 | $-90 | $34 | $206,424 | $203,920 |
| Exchange Rate Effect | 2,546 | 13,640 | 11,241 | -6,327 | -2,641 |
| Beginning Cash Position | 76,154 | 245,079 | 254,325 | 158,426 | 156,356 |
| End Cash Position | 81,609 | 79,010 | 141,366 | 267,716 | 313,470 |
| Net Cash Flow | $5,455 | $-166,069 | $-112,959 | $109,290 | $157,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,819 | -97,588 | -51,026 | -85,469 | -39,126 |
| Free Cash Flow | -29,819 | -97,588 | -51,026 | -85,469 | -39,126 |